Filter
1325
Featured
148
537
Language
Document type
1116
49
39
26
18
18
18
17
12
8
3
1
Countries / Regions
339
316
272
187
124
112
109
106
101
55
54
50
40
35
34
31
27
25
21
16
13
12
10
8
7
6
6
5
4
4
4
3
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
100
97
45
25
13
8
6
Clinical managment
recommended
Quality clinical care is at the heart of a robust, effective response to outbreaks. Frontline health workers need evidence-based tools and training to provide safe, effective and quality clinical care.
The Clinical Management channel includes videos on a range of diseases, such as Ebola, diphther
...
WHO guideline on contact tracing
recommended
This practical guideline establishes definitions for “contact”, “contact person”, “contact tracing” and other associated concepts. It allows for improvement of contact tracing strategies and provides recommendations attempting to answer some, though not all, questions that arose during t
...
Sudan virus disease is a severe, often fatal illness affecting humans and other primates that is due to Orthoebolavirus sudanense (Sudan virus), a viral species belonging to the same genus of the virus causing Ebola virus disease. This webinar will provide an overview of the current outbreak of Suda
...
The African region reports the highest number of health emergencies of all the WHO regions every year: an average of
2-3 new events every week
This question bank is a menu of qualitative questions related to healthcare workers’ knowledge, perceptions and practices during infectious disease outbreaks. The question bank will generate qualitative data on healthcare workers’ subjective understandings of risks, case management, protection a
...
Cette banque de questions est un menu de questions qualitatives relatives aux connaissances, aux perceptions et aux pratiques du personnel de santé lors d'épidémies de maladies infectieuses. La banque de questions générera des données qualitatives sur la compréhension subjective qu'ont les pr
...
This toolkit is a comprehensive set of practical tools and resources designed to support country-level risk communication and community engagement (RCCE) practitioners, decision-makers and partners to plan and implement readiness and response activities for Ebola disease outbreaks. The toolkit conta
...
On 4 September 2025, the Ministry of Health of the Democratic Republic of the Congo (DRC) declared an outbreak of Ebola Virus Disease (EVD) in Kasai Province, following confirmation of Zaire ebolavirus by the National Institute of Biomedical Research (INRB) in Bulape and Mweka Health Zones. As of 19
...
This channel offers learning resources for strategic health operations, including Ebola and Marburg diseases screening and treatment center design, ultra-low temperature vaccine management and WHO Mobile Very Small Aperture Terminal installation.
La fièvre de Lassa est une fièvre hémorragique virale aiguë d'une durée d'une à quatre semaines qui sévit en Afrique occidentale. La fièvre de Lassa, une fièvre hémorragique virale avec des symptômes similaires à ceux de la maladie virale d'Ebola, est endémique dans une grande partie de
...
Lassa fever, a viral haemorrhagic fever with symptoms similar to those of Ebola virus disease, is endemic in much of West Africa and usually sparks a seasonal outbreak from December to March. Humans usually become infected with Lassa virus from exposure to urine and faeces of infected Mastomys rats.
...
The primary objective of this curriculum is to equip health and care workers with the essential knowledge and competencies necessary for delivering safe and effective care. By doing so it aims to significantly reduce HAIs and combat antimicrobial resistance, thereby safeguarding both patient and HCW
...
Ebola virus (EBOV) and Marburg virus (MARV) are associated with severe, potentially fatal, systemic diseases. During the development of the Infection Prevention and Control Guideline for Ebola Disease and Marburg Disease, the Guideline Development Group (GDG) identified multiple research gaps in key
...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in humans and,
although uncommon, it has the potential to cause epidemics with significant case fatality.
...
Marburg virus disease (MVD), formerly known as Marburg haemorrhagic fever, is a severe disease in humans caused by Marburg marburgvirus (MARV). Although MVD is uncommon, MARV has the potential to cause epidemics with significant case fatality rates.
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedi
...
Situation Report
Fact Sheet
Training: Infection Prevention and Control for Marburg Virus Disease in Non-U.S. Healthcare Settings
These training materials apply to all healthcare facilities that are not designated MVD treatment facilities.
